Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation

被引:27
作者
Goncalves-Araujo, Tamara [1 ]
Rajabi-Siahboomi, Ali R. [2 ]
Caraballo, Isidoro [1 ]
机构
[1] Univ Seville, Dept Farm & Tecn Farmaceut, Seville 41012, Spain
[2] Colorcon, West Point, PA 19486 USA
关键词
Verapamil HCl; percolation theory; hydroxypropylmethylcellulose; hypromellose; hydrophilic matrix; extended release;
D O I
10.1016/j.ijpharm.2008.05.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The percolation theory studies the critical points or percolation thresholds of the system, where one component of the system undergoes a geometrical phase transition, starting to connect the whole system. The objective of the present paper was to study the existence of critical points governing the water and drug transport inside hydroxypropylmethylcellulose (HPMC) hydrophilic matrix systems obtained with different polymer viscosity grades. For this purpose, extended release formulations of Verapamil HCl, have been prepared and studied. The percolation theory has been applied for the first time to multi-component hydrophilic matrices. The materials used to prepare the tablets were Verapamil HCl, four different viscosity grades of HPMC, microcrystalline cellulose, lactose, magnesium stearate and colloidal silicon dioxide NF. In order to estimate the percolation threshold, the behaviour of the kinetic parameters with respect to the volumetric fraction of each component at time zero, was studied. From the point of view of the percolation theory, the optimum concentration for all the studied polymers, to obtain a hydrophilic matrix system for the controlled release of Verapamil HCl is higher than 20% (v/v) HPMC. Above 20% (v/v) HPMC, an infinite cluster of excipient would be formed, ensuring uniform hydration, maintaining integrity of the system and controlling the drug release. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 13 条
  • [1] Relationship between drug percolation threshold and particle size in matrix tablets
    Caraballo, I
    Millan, M
    Rabasco, AM
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (03) : 387 - 390
  • [2] Caraballo I, 2004, EUR C DRUG DEL PHARM, P145
  • [3] Davidson G.W.R., 1986, J. Control. Release, V3, P243, DOI [DOI 10.1016/0168-3659(86)90096-9, 10.1016/0168-3659(86)90096-9]
  • [4] Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets
    Fuertes, Inmaculada
    Miranda, Antonia
    Millan, Monica
    Caraballo, Isidoro
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (03) : 336 - 342
  • [6] MECHANISMS OF SOLUTE RELEASE FROM POROUS HYDROPHILIC POLYMERS
    KORSMEYER, RW
    GURNY, R
    DOELKER, E
    BURI, P
    PEPPAS, NA
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 15 (01) : 25 - 35
  • [7] The role of the drug/excipient particle size ratio in the percolation model for tablets
    Millán, M
    Caraballo, I
    Rabasco, AM
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (02) : 216 - 220
  • [8] Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery
    Miranda, A
    Millán, M
    Caraballo, I
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 311 (1-2) : 75 - 81
  • [9] Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets
    Miranda, Antonia
    Millan, Monica
    Caraballo, Isidoro
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (10) : 2746 - 2756
  • [10] Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery
    Miranda, Antonia
    Millan, Monica
    Caraballo, Isidoro
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (05) : 598 - 602